Select a community
All Communities
Home > Community Treatment Reports > Glatiramer acetate Treatment Report
What is Glatiramer acetate?

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Side Effects

Side effects as an overall problem

Severe
46 9%
Moderate
74 15%
Mild
246 50%
None
127 26%

Most commonly reported side effects

lumps
263 53%
Injection site reaction
234 47%
redness
218 44%
Injection site itching
205 42%
Injection site pain
188 38%
Bruising
143 29%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Glatiramer acetate. See all 38 dosages ►

  20mg as needed 20mg/mL as needed 20mg weekly daily 1 mL weekly 0.2 mg daily 1 daily 1 g daily 1 mg daily 1 mL daily 2 mg daily 20 mg weekly 5 mg daily 40 mg weekly 10 mg daily 20 mg 20 mg every other day 13 mg daily 15 mg daily 20 daily 20 mcg daily 20 mg daily 20 mg one time 22 mg daily 25 mg daily 30 mg daily 40 mg daily 44 mg daily 50 mg daily 60 mg daily 80 mg daily 81 mg daily 100 mg daily 120 mg daily 200 mg daily 250 mg daily 300 mg daily 1200 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 241 Number of Patients: 241 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 42 Number of Patients: 42 4 Number of Patients: 4 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1 29 Number of Patients: 29 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1576 Number of Patients: 1576 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 7 Number of Patients: 7 8 Number of Patients: 8 3 Number of Patients: 3 3 Number of Patients: 3 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
279 38% Did not seem to work: 38%
Side effects too severe
247 34% Side effects too severe: 34%
Doctor's advice
182 25% Doctor's advice: 25%
Other
142 19% Other: 19%
Expense
53 7% Expense: 7%
Personal research
32 4% Personal research: 4%
Not indicated
12 2% Not indicated: 2%
Course of treatment ended
7 1% Course of treatment ended: 1%

See all 701 patients who’ve stopped taking Glatiramer acetate

Duration See details about how long patients take this treatment ▼

Currently Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
9
37
79
200
206
397

Stopped Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
35
68
97
142
129
219

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
380 77%
Usually
87 18%
Sometimes
19 4%
Never
7 1%

Burden

Difficulty being on treatment

Very
43 9%
Somewhat
98 20%
A little
217 44%
Not at all
135 27%

Cost

Paid out of pocket

$200+
45 9%
$100-199
17 3%
$50-99
35 7%
$25-49
87 18%
< $25
184 37%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.